This interactive 90-minute training provides medical and nurse practitioners who prescribe HBV antiviral medications an opportunity to apply their knowledge and skills to practical case studies.
Case scenarios are developed by ASHM clinical advisors or local experts to meet the identified learning needs of medical practitioners, which vary from each State and Territory.
Attendees are also encouraged to submit their own de-identified cases for discussion. Please send any cases to [email protected] by 28 October 2026.
Click here to view our downloadable flyer!
Date, Time, and Platform:
- Date: Wednesday, 4 November 2026
- Time: 6:30pm – 8:00pm (ACST)
- Platform: Live Online – Zoom
Speakers:
- A/Prof Jane Davies | ID Physician | Menzies School of Health Research
Learning Outcomes:
On completion of this course and its components, participants will be able to:
- Plan guideline-based monitoring for patients with chronic hepatitis B
- Evaluate chronic hepatitis B patients’ suitability for antiviral treatment
- Select and prescribe appropriate first-line antiviral medication for patients with chronic hepatitis B
Components:
- One 90-minute online case discussion
- Post course survey
Recommended Resources:
- Click here to access Decision Making In Hepatitis B
- Click here to access Decision Making In Hepatitis B – NT Version
CPD and Endorsement:
- RACGP: This is an approved activity under the RACGP CPD Program. Activity number 1522286.
1.5 Educational Hours - ACRRM: This event has been accredited in the 2026-2028 ACRRM CPD Program.
1.5 Educational Hours - ACNP: This activity is endorsed by the Australian College of Nurse Practitioners (ACNP) for 1.5 hours
Funding:
This activity is funded by Northern Territory of Australia Department of Health.
Target Audience:
Medical and Nurse Practitioners who have previous experience and knowledge of hepatitis B or who manage and prescribe hepatitis B s100 medications.
